1. National Center for Cardiovascular Diseases, China. Report on cardiovascular diseases in China (2016). Beijing: Encyclopedia of China Publishing House; 2017:1–2.
2. Falk E, Nakano M, Bentzon J F, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eu Heart J 2013;34:719–728.
3. Xu H, Qu D, Zheng F, Shi DZ, Chen KJ. Clinical manifestations of “blood-stasis and toxin” in patients with stable coronary heart disease. Chin J Integr Tradit West Med (Chin) 2010;30:125–129.
4. Ma XJ, Guo CY, Zhang Y, Wang L, Yin HJ, Shi DZ. Role of promoting blood circulation and its combination with detoxication in protecting AMI rats against myocardial injury. Chin J Geriatric Heart Brain Vessel Dis (Chin) 2015;17:960–963.
5. Tang SM, Xing XY, Deng XH, Zhao NN, Li G, Yang RC, et al. Research progress of Guanxin Danshen Formula and its effective components in treating coronary artery heart disease. Chin J Chin Mater Med 2016;41:3721–3726.